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OBJECTIVE: Apolipoprotein E4 may benefit children during early periods of life when the body is challenged by
infection and nutritional decline. We examined whether apolipoprotein E4 affects intestinal barrier function,
thereby improving short-term growth and long-term cognitive outcomes in Brazilian shantytown children.
METHODS: A total of 213 Brazilian shantytown children with below-median height-for-age z-scores (HAZ) received
200,000 IU of retinol (every four months), zinc (40 mg twice weekly), or both for one year, with half of each group
receiving glutamine supplementation for 10 days. Height-for-age z-scores, weight-for-age z-scores, weight-for-
height z-scores, and lactulose:mannitol ratios were assessed during the initial four months of treatment. An average
of four years (range 1.4-6.6) later, the children underwent cognitive testing to evaluate non-verbal intelligence,
coding, verbal fluency, verbal learning, and delayed verbal learning. Apolipoprotein E4 carriage was determined by
PCR analysis for 144 children.
RESULTS: Thirty-seven children were apolipoprotein E4(+), with an allele frequency of 13.9%. Significant associations
were found for vitamin A and glutamine with intestinal barrier function. Apolipoprotein E4(+) children receiving
glutaminepresentedsignificantpositive Pearsoncorrelationsbetweenthechange inheight-for-age z-scores overfour
months and delayed verbal learning, along with correlated changes over the same period in weight-for-age z-scores
and weight-for-height z-scores associated with non-verbal intelligence quotients. There was a significant correlation
between vitamin A supplementation of apolipoprotein E4(+) children and improved delta lactulose/mannitol.
Apolipoprotein E4(-) children, regardless of intervention, exhibited negative Pearson correlations between the
change in lactulose-to-mannitol ratio over four months and verbal learning and non-verbal intelligence.
CONCLUSIONS: During development, apolipoprotein E4 may function concomitantly with gut-tropic nutrients to
benefit immediate nutritional status, which can translate into better long-term cognitive outcomes.
KEYWORDS: APOE4; Malnutrition; Cognitive Outcomes; Intestinal Permeability; Glutamine.
Mitter SS, Oria ´ RB, Kvalsund MP, Pamplona P, Joventino ES, Mota RMS, et al. Apolipoprotein E4 influences growth and cognitive responses to
micronutrient supplementation in shantytown children from northeast Brazil. Clinics. 2012;67(1):11-18.
Received for publication on August 25, 2011; First review completed on September 12, 2011; Accepted for publication on September 12, 2011
E-mail: rbo5u@virginia.edu
Tel.: 55 85 3366-8239
INTRODUCTION
Shantytown children living in crowded households,
raised in low-income families and exposed to poor hygiene
are at particular risk of malnutrition and enteric disease
early in life. The vicious cycle of diarrhea and malnutrition
may even occur without overt diarrhea due to various
degrees of small intestinal barrier dysfunction and poor
nutrient absorption (1,2).
Childhood malnutrition associated with subclinical/clin-
ical enteric illnesses, including diarrheal disease, can be
potentially devastating by causing deleterious long-term
effects on development (2,3), stunting, wasting, impaired
cognition, and poorer school performance (4,8). It is
estimated that malnutrition in children below the age of
five accounts for 11% of global total disability-adjusted life
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11years (DALYs) (9), and the combined direct and indirect
effects of malnutrition and micronutrient deficiencies
account for roughly one-third of the disease burden in
developing countries (10). Management of malnutrition
includes implementing dietary changes, improving hygiene,
and eliminating enteric infections. However, host genetics
should also be investigated to understand differential
outcomes arising from the treatment of malnutrition and
diarrheal disease early in life.
Apolipoprotein E (ApoE) is a critical carrier protein
involved in lipid homeostasis. ApoE carries cholesterol from
somatic cells to the liver for metabolization (11). The human
APOE gene has three alleles at its locus on chromosome 19:
APOE2; APOE3, the most frequent allele; and APOE4,
which is often associated with atherosclerosis and late-onset
Alzheimer’s disease (11,12). Despite these potential later-life
APOE-associated problems, this gene may obey the princi-
ple of antagonistic pleiotropy, such that despite potentially
detrimental effects later in life, certain polymorphisms may
actually be beneficial during critical periods of development
when the body faces infection and nutritional decline
(13,14). For this reason, more attention is now being paid
to APOE polymorphisms and their varied effects on growth
and cognitive outcomes during childhood (15,16).
When considering management of the cycle of malnutri-
tion and enteric illness and the associated long-term effects,
the question remains as to whether host genetics plays a role
in Brazilian shantytown children receiving micronutrient
supplementation in an endemic area for under-nutrition and
enteric infections. We therefore sought to determine whether
APOE genotype affects short-term growth and nutritional
gains associated with glutamine, zinc, and/or vitamin A
supplementation. In addition, we investigated how various
forms of nutritional supplementation may affect APOE4
carriers living in a setting where there is endemic diarrhea
and malnutrition with particular consideration of long-term
cognitive outcomes and how such information correlates
with lactulose-mannitol urinary excretion, a well-known
marker of intestinal barrier function.
MATERIALS AND METHODS
Ethics. The study protocol and informed consent forms
were approved by the institutional review boards of the
Federal University of Ceara ´ and the University of Virginia.
In addition, the protocol and consent were registered as part
of clinical trial NCT00133406 with the National Institutes of
Health.
Population. The study population was located in the
Parque Universita ´rio community (3˚44958.270 south and
38˚34930.800 west) of Fortaleza, Ceara ´ in northeast Brazil,
5 km from the Clinical Research Unit and Institute of
Biomedicine/Center for Global Health (www.upcibimed.
ufc.br) laboratories in Fortaleza. Fortaleza has an estimated
population of 2.6 million inhabitants and an infant mortality
rate of 35 deaths per 1,000 live births. A 1998 census of
Parque Universita ´rio indicated that it contained a total
population of 3,541 inhabitants, of which 957 (27%) were
children under the age of nine. The parents or guardians of
children were invited to participate in the study after
informed consent was obtained.
Study Design, Eligibility, and Exclusion Criteria for
Enrollment of Subjects. This study is part of a prospec-
tive, randomized trial (phase III) involving micronutrient
supplementation of undernourished children. The following
eligibility criteria were used for enrollment of subjects:
children from two months to nine years of age with a
height-for-age z-score (HAZ) less than the median (–0.06)
residing in the Parque Universita ´rio community for whom
parental or guardian consent was obtained. Children were
excluded if they had been participants in any study in the past
two years or were ill with a fever .38˚Ca tt h et i m eo f
enrollment.
Nutritional Interventions and Surveillance. Two-
hundred thirteen children were randomized with respect
to receiving vitamin A (100,000 IU retinyl palmitate if ,12
months old or 200,000 IU retinyl palmitate if $12 months
old every four months), zinc (40 mg twice weekly), or both
for 1 year, with half of each group receiving glutamine (16 g
daily). Trained health care agents administered all of the
micronutrients.
A field team comprised of a local nurse and three health
care agents performed anthropometric measurements every
month in the first four months of nutritional supplementa-
tion. Height and length were measured with the child in the
supine position for children less than two years old and
in the standing position for children two years of age and
older to the nearest 0.1 cm using a measuring board. HAZ,
weight-for-age z-scores (WAZ), and weight-for-height z-
scores (WHZ) were calculated using the anthropometric
software Epi-Info (Center for Disease Control, Atlanta, GA,
USA) as markers of physical development and nutritional
status.
The field team also performed intestinal permeability
testing using a previously described method (17,18). For
testing during the initial four months of supplementation,
fasted children ingested (2 mL/kg of weight, maximum
20 mL) standard solutions containing lactulose (250 mg/
m L ;L a c t u l o n a ,L u i t p o l dP r o d u t o sF a r m a c e ˆuticos Ltda,
Sa ˜o Paulo, SP, Brazil) and mannitol (50 mg/mL; Manitol,
Henri Farma Produtos Quı ´micos e Farmace ˆuticos Ltda,
Sa ˜o Paulo, SP, Brazil). Ingestion was followed by collection
of urine 5 hours thereafter using flasks containing 50 mL
of chlorhexidine (40 mg/mL; Sigma Chemical St Louis,
MO, USA) per 50 mL of urine. Lactulose and mannitol
concentrations were determined by HPLC (high-perfor-
mance liquid chromatography) using pulsed ampero-
metric detection (18), and the integration and
quantification of isolated peaks in the chromatograms
were completed using Peak Net software (Dionex,
Sunnyvale, CA, USA). The final percentage of excreted
urinary sugars was calculated using Excel (Microsoft,
Redmond, WA, USA). The result of the lactulose:mannitol
permeability test was considered abnormal (positive)
during comparison if the lactulose-to-mannitol ratio (L/
M) was $0.0864 (based on a previous calculation of a
normal mean plus two standard deviations) (18).
Cognitive Testing. A short battery of selected cognitive
tests to assess executive function, intelligence quotients and
language skills was administered with instructions given in
Portuguese in a quiet room by the study neuropsychologist to
study participants an average of 4 years (range 1.6-4.4 years)
post-enrollment into the study. The battery included tests for
the non-verbal intelligence quotient (TONI-3, Pro-Ed, USA),
coding tasks (WISC-III, The Psychological Corporation, USA),
verbal fluency (NEPSY, The Psychological Corporation,
USA), verbal learning (WRAML, Psychological Assessment
Resources,Inc., USA), and delayedverbal learning (WRAML).
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12Blood Collection and DNA Extraction. Blood was
obtained from 144 (67.6%) children from the original study
population. DNA was then extracted from the blood
samples using the QIAamp DNA Blood Mini Kit (Qiagen,
Germantown, MD, USA) following the manufacturer’s
suggested protocol.
APOE Genotyping. The experimental protocol for APOE
genotyping involved amplification of APOE sequences
from genomic DNA followed by digestion with the HhaI
restriction enzyme (19). A 270-bp DNA sequence from the
blood samples was amplified by PCR in a thermal cycler
using the oligo-nucleotide primers 59-GCACGGCTGTC-
CAAGGAGCTGCAGGC-39 and 59-GGCGCTCGCGGATG-
GCG CTGAG-39 as first described by Addya et al. (20). PCR
Master Mix and GoTaq Green polymerase were obtained
from Promega Corporation (Fitchburg, WI, USA). Each
amplification reaction contained 2.5 ml of blood DNA, 2.5 ml
of each primer, and 10% DMSO in a final volume of 50 ml.
The PCR conditions included an initial 95˚C 5-minute cycle
followed by 40 cycles of 95˚C for 15 seconds, 62˚C for 15
seconds, and 72˚C for 45 seconds before a final extension at
72˚C for 4 minutes and holding at 4˚C. Following PCR
amplification, 15 ml of each amplified PCR product was
electrophoresed in a 2% Ultrapure agarose gel (Invitrogen,
Carlsbad, CA, USA) in 1x Tris-acetate-EDTA (TAE) buffer.
The gels were then washed in an ethidium bromide solution
for 15 minutes and visualized under UV illumination to
confirm the presence of a 270-bp amplification product. A
restriction digest using 1 ml of HhaI (New England Biolabs,
Ipswich, MA, USA) and 20 ml of confirmed amplified PCR
products was conducted in a thermal cycler at 37˚C for
3 hours. Each reaction mixture was loaded into a 4%
agarose gel (3% NuSieve GTG, Cambrex Corporation, East
Rutherford, NJ, USA+1% Ultrapure) in 0.5x TBE solution
and electrophoresed for 1 hour under constant voltage
(100 V). The electrophoresed gels containing the digested
DNA products were then washed in an ethidium bromide
solution for 30-45 minutes and visualized under UV
illumination. The sizes of the HhaI-digested fragments
were estimated by comparison with known DNA ladders
for determination of APOE genotypes. Ambiguous APOE
genotypes were reanalyzed by repetition of the previously
described protocol.
Statistical Analysis. All data were analyzed using the
SPSS statistical software package (SPSS, Inc., Chicago, IL,
USA). Allelic frequencies were determined by counting the
different alleles present based on RFLP (restriction fragment
length polymorphism) analysis and calculating their pro-
portions. The demographic characteristics of the participants
were described in terms of rates and percentages. Subgroups
for statistical analysis were assigned based on nutritional
intervention. All children receiving vitamin A, all children
receiving zinc, and all children receiving glutamine were
pooled to increase the numberofindividuals in each subgroup
and to increase the power of the analysis. Analyses of
contingency tables were conducted to investigate categorical
variables based on the nutritional intervention applied using
the Fisher’s exact test. We determined Pearson linear
correlation coefficients for the nutrient subgroups stratified
by APOE4 carriage to assess the association between the
change in anthropometric and/or intestinal permeability
indicators during the initial 4 months of supplementation
and the battery of cognitive tests performed years later. A
p#0.05 was considered to be statistically significant.
RESULTS
To assess how the presence of the APOE4 allele influences
anthropometric outcomes, intestinal permeability and cog-
nitive outcomes following early nutritional intervention, we
performed APOE genotyping (Figure 1) of Brazilian shanty-
town children living in a diarrheal disease and malnutrition
endemic area who manifested various degrees of intestinal
barrier dysfunction and under-nutrition, which were con-
firmed by high L/M ratios and low anthropometric markers
at baseline, respectively. Overall, the frequency of the
APOE3 allele in our study group was found to be similar
to frequencies commonly found in the literature (82.29%
vs. 79%), while the frequency of the APOE2 allele was
lower than what is normally reported (3.82% vs. 7.3%) (21).
The frequency of the APOE4 allele was consistent with
frequencies reported in other populations (13.9%) (21),
while the allele was present in 37 of the children tested
(25.7% of the analyzed population) (Table 1). Demographic
data describing the study population, including sex, birth
weight, age at enrollment, age at cognitive testing, maternal
education and household income, and crowding, were
assessed and segregated based on the presence of the
APOE4 allele (Table 2). We expected that breastfeeding
would not be an issue as a prospective confounder for the
cognitive tests as the mean ages at enrollment and cognitive
testing of APOE4-positive children were 51.13 months
and 103.2 months, respectively, while for APOE4-negative
children, they were 55.47 months and 106.1 months,
respectively, which are ages when the children would be
fully weaned, given the short duration of breastfeeding in
northeastern Brazil (average 65 days) (22). The proportion
of males was 59.5% and 44.9% for the APOE4-positive
and APOE4-negative groups, respectively. No statistically
Figure 1 - The gel electrophoresis banding patterns used to
genotype amplified DNA of study subjects digested with the
HhaI restriction enzyme were as follows: (Column 1) 50-basepair
DNA ladder; (Column 4) APOE2,3 genotype; (Column 5) APOE3,3
genotype; (Column 6) APOE3,4 genotype; (Column 7) APOE4,4
genotype; (Column 8) 100-basepair DNA ladder.
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13significant differences were found for any of the aforemen-
tioned demographic parameters between the APOE4-posi-
tive and APOE4-negative groups. The z-scores (Table 2) for
height (to evaluate stunting), weight and WHZ (wasting)
were not significantly different between the APOE4-positive
and APOE4-negative groups at baseline. Abnormal L/M
ratios $0.0864, as defined by Barboza et al. (18), were found
in 37.9% and 40.1% of the APOE4-positive and APOE4-
negative populations at baseline, respectively (Table 2),
which were also not statistically significantly different. After
four months of nutritional intervention, the change in L/M
from baseline in all of the supplement subgroups showed
mean improvements (decrease) of -0.004, -0.159, and -0.124
for APOE4-positive children receiving glutamine, zinc, and
vitamin A, respectively, and of -0.032, -0.046, and -0.043 for
APOE4-negative children receiving glutamine, zinc, and
vitamin A, respectively. No direct benefit or detriment of
the APOE4 allele with respect to cognitive function among
the supplement subgroups after the initial four months
of intervention could be detected in the analyzed data
(p.0.05).
To evaluate the benefits of the applied nutritional
interventions for intestinal barrier function and, conse-
quently, improved growth, we conducted Pearson correla-
tion analyses of the changes in the L/M ratio and the
anthropometric parameters from baseline to four months of
nutritional supplementation. By analyzing each nutrient
arm group, we found significant improvements in amelior-
ating delta WAZ and WHZ scores in association with
vitamin A and glutamine (Table 3).
After stratifying the pooled supplementation groups
based on the presence of the APOE4 allele, we found a
significant effect associated with carrying APOE4 and better
delta L/M ratios only related to vitamin A supplementation
and not for the hydrophilic glutamine and zinc interven-
tions, suggesting an interaction of ApoE and liposoluble
vitamin A in ameliorating intestinal barrier function
(Table 4).
Pearson correlation analysis was also performed to
analyze the effects of genetics and the type of micronutrient
supplementation on changes in anthropometric indicators
after the initial four months of the intervention and long-
term cognitive outcomes. Only the children in the glutamine
supplementation arm who were APOE4 positive exhibited
significant correlations between short-term anthropometric
gains and long-term cognitive outcomes. Improvements in
HAZ were correlated with higher WRAML-delayed verbal
learning scores (r=0.477, p=0.029, n=21), while improve-
ments in WAZ and WHZ were correlated with better TONI-
3-IQ scores (r=0.470, p=0.032, n=21 and r=0.502, p=0.020,
n=21, respectively) (Figure 2).
There was a noteworthy trend of improved intestinal
permeability after four months of micronutrient supple-
mentation as well as improved WRAML-verbal learning
and TONI-3-IQ scores for APOE4-negative children in
each micronutrient arm of the study, but these associations
never quite reached statistical significance (Table 5). In the
glutamine arm of the trial, the change in L/M over the
four months of the study was negatively correlated with
WRAML-verbal learning and TONI-3-IQ scores (r=-0.295,
p=0.076, n=37 and r=-0.305, p=0.066, n=37, respectively)
among APOE4 non-carriers. Similarly in the zinc arm, the
Pearson correlation coefficients between L/M and WRAML-
verbal learning and TONI-3-IQ were r=-0.431 (p=0.008,
n=37) and r=-0.428 (p=0.008, n=37), respectively, while
for vitamin A, the Pearson correlation coefficients were r=
-0.425 (p=0.012, n=34) and r=-0.332 (p=0.055, n=34),
respectively. In addition in the vitamin A arm, a significant
Table 2 - Demographic and anthropometric data for the
Parque Universita ´rio study population at baseline
segregated by APOE4 allele status.
Study Population
Characteristics APOE4(+) APOE4(-)
Sex
Female 15 (40.5%) 59 (55.1%)
Male 22 (59.5%) 48 (44.9%)
Birth weight (g) 3100¡484 (n=36) 3143¡526 (n=102)
Mean age at enrollment (m) 51.13¡30.30
(n=37)
55.47¡26.32
(n=107)
Mean age at cognitive
testing (m)
103.2¡29.00
(n=37)
106.1¡24.42
(n=107)
Maternal education
Below primary school 26 (70.3%) 89 (83.2%)
Primary school or above 9 (24.3%) 18 (16.8%)
Unknown 2 (5.4%) —
Monthly income* minimum
salary
,2 25 (67.6%) 64 (59.8%)
$2 2 (5.4%) 15 (14.0%)
Unknown 10 (27.0%) 28 (26.2%)
Household crowding ($3
persons/room)
No 18 (48.6%) 45 (42.1%)
Yes 19 (51.4%) 61 (57.0%)
Unknown — 1 (0.9%)
HAZ** , -1
No 20 (54.1%) 60 (56.1%)
Yes 17 (45.9%) 47 (43.9%)
WAZ** , -1
No 22 (59.5%) 61 (57.0%)
Yes 15 (40.5%) 46 (43.0%)
WHZ** , -1
No 31 (83.8%) 85 (79.4%)
Yes 6 (16.2%) 22 (20.6%)
L/M** . 0.0864
No 18 (62.1%) 55 (59.1%)
Yes 11 (37.9%) 38 (40.9%)
*1 minimum wage: US $102/month.
**HAZ, WAZ, WHZ, L/M at study enrollment.
Table 1 - Genotypic and allelic distribution of APOE in the
analyzed population of the Parque Universita ´rio
community in Fortaleza, Ceara ´, Brazil.
Genotype* Number Frequency (%)
e2e2 0 0.00
e2e3 10 6.94
e2e4 1 0.69
e3e3 97 67.36
e3e4 33 22.92
e4e4 3 2.06
Total 144 100
Allele* Number Frequency (%)
e2 11 3.82
e3 237 82.29
e4 40 13.89
Total 288 100
*e2=APOE2, e3=APOE3, e4=APOE.
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14Pearson correlation of r=-0.385 (p=0.025, n=34) was found
between L/M and WRAML-delayed verbal learning in
APOE4 non-carriers. To confirm that this effect was not
evident at baseline, prior to micronutrient supplementation,
Pearson correlation coefficients were generated between L/
M at baseline and the battery of cognitive tests for the entire
study population as well for populations segregated by
APOE4 allele status. No trend or statistical significance was
detected during these assessments.
DISCUSSION
The shantytown children addressed in this study pre-
sented with varying nutritional backgrounds, with a high
prevalence of undernourishment (HAZ, WAZ and/or WHZ
,-1) and intestinal barrier dysfunction at enrollment being
detected by L/M assays, presumably suggesting underlying
enteric illnesses early in life. The etiology of such diseases
varies; however, roughly 40% of the children presented with
an abnormal L/M at baseline, implying intestinal break-
down as a result of clinical/subclinical enteric disease,
which could contribute to poorer nutrition. Intermittent or
continuous intestinal challenges caused by enteric disease
with varying degrees of virulence can impair the body’s
ability to absorb and utilize nutrients for physical as well as
full brain development.
Previous studies by our group found beneficial roles for
glutamine, zinc, and vitamin A in ameliorating the combined
effects of malnutrition and heavy diarrhea burdens on
physical growth and cognitive function (23,24). Host genetics
may also play a critical role in determining the outcomes of
malnutrition and enteric infections by affecting the degree of
intestinal nutrient absorption and homeostasis, although
these relationships are mostly unknown.
ApoE is primarily responsible for regulating cholesterol
transport and metabolism in liver tissue and plasma
(11,25). The brain is also a site of high ApoE expression
(26,27). Investigations into the involvement of ApoE in the
central nervous system (CNS) have notably found roles in
traumatic brain injury and Alzheimer’s disease via
immuno-inflammatory mediation (12,28). Functionally,
ApoE may be involved in neuronal plasticity during CNS
development. Evidence points to the ApoE-cholesterol
complex operating as a critical glial factor in synaptogen-
esis, which may also subsequently affect long-term synap-
tic plasticity (29,30). Despite the associations found with
neurodegenerative changes late in life, there is a lack of
consensus regarding the effects of the APOE4 allele on
cognitive function in children. While some studies in
children report memory deficits among APOE4 carriers
(31), other APOE4 genotyping studies in children are
finding associations with better cognitive function (13,32),
necessitating further work to determine APOE4’s role in
pediatric populations.
Additionally, it has been suggested that APOE plays a
role in intestinal development. Rat models indicate that
there is an increase in ApoE mRNA in the liver at birth and
during suckling in post-natal development. In response to a
10-hour fast, suckling rats also present an increase in liver
ApoE mRNA, implying that hepatic APOE expression is
subject to fluctuations in serum insulin and glucagon (33).
Furthermore, ApoE may help establish the integrity of tight
junctions in the intestinal lining, similar to its role at the
blood-brain barrier (3,34).
In comparison to the most common APOE3 allele, the
APOE4 allele is associated with less severe diarrheal
outcomes, including those related to both stunting and
wasting, as well as improved cognition in individuals with
severe diarrheal disease (13,14), whereas possession of
APOE2 is associated with poorer visuospatial skills during
childhood (15). Additionally, the presence of APOE4 is
associated with increased intestinal cholesterol absorption
during development (35). Compared to populations of more
agricultural societies, the prevalence of APOE4 is higher
among communities at greater risk for starvation and with
Table 3 - Pearson correlations between the change in the lactulose:mannitol (L/M) ratio (an intestinal permeability
indicator) during the initial 4 months of nutritional supplementation and DHAZ* (t4-t0), DWAZ* (t4-t0) and DWHZ*
(t4-t0) according to the experimental nutrition groups.
DL/M(t4-t0)
Gln Zn Vit. A Vit. A+Zn Zn+Gln Vit. A+Gln Vit. A+Zn+Gln
N rp -value N rp -value N rp -value N rp -value N rp -value N rp -value N rp -value
DHAZ 16 -0.005 0.986 11 -0.509 0.110 8 0.326 0.431 12 -0.333 0.291 13 0.305 0.310 15 0.061 0.829 9 0.013 0.974
DWAZ 16 0.277 0.299 11 0.071 0.836 8 0.494 0.213 12 -0.512 0.088 13 -0.411 0.164 15 -0.593 0.020 9 0.489 0.182
DWHZ 16 0.251 0.348 11 0.429 0.188 8 0.247 0.555 12 -0.383 0.219 13 -0.404 0.171 15 -0.554 0.032 9 0.268 0.485
*HAZ = height-for-age z-scores, WAZ = weight-for-age z-scores, WHZ = weight-for-height z-scores.
Gln = glutamine; Zn = zinc; Vit. A = vitamin A.
Table 4 - Pearson correlations between the change in the
lactulose:mannitol (L/M) ratio (an intestinal permeability
indicator) during the initial 4 months of nutritional
supplementation and DHAZ* (t4-t0), DWAZ* (t4-t0) and
DWHZ* (t4-t0) according to APOE4 genotyping.
DL/M(t4-t0)
APOE4(+) APOE4(-)
N r p-value N rp - value
Glutamine nHAZ 16 0.137 0.613 37 0.122 0.470
nWAZ 16 -0.132 0.625 37 -0.036 0.834
nWHZ 16 -0.134 0.622 37 -0.096 0.572
Zinc nHAZ 8 0.165 0.697 37 0.001 0.995
nWAZ 8 -0.583 0.130 37 -0.105 0.534
nWHZ 8 -0.460 0.251 37 -0.115 0.500
Vitamin A nHAZ 10 -0.014 0.970 34 -0.101 0.569
nWAZ 10 -0.654 0.040 34 0.260 0.137
nWHZ 10 -0.470 0.171 34 0.263 0.132
*HAZ=height-for-age z-scores, WAZ=weight-for-age z-scores,
WHZ=weight-for-height z-scores.
APOE4(+)=children carrying genotypes 3/4; 2/4; 4/4.
APOE4(-)=children carrying genotypes 2/2; 3/2; 3/3.
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15tenuous food supplies, suggesting that APOE4 may aid in
lipid absorption (36). There may be a nutritional axis
involved in these processes, such that an intact intestinal
membrane allows for better nutrient absorption, which
translates into better growth outcomes and better cognitive
development. However, even among our study population,
the frequency of APOE4 was in accordance with data from
our previous studies on the local communities in Fortaleza,
Brazil as well as global estimates (16,21).
To date, there have been no studies that have addressed
how allelic variations in APOE may work in concert
with micronutrient supplementation and differentially affect
growth and cognitive outcomes in under-nutritioned chil-
dren. The results of the present study indicate that APOE4-
positive children receiving glutamine supplementation in
particular presented improved short-term gains in HAZ,
WAZand WHZthatwere correlatedwithbetterperformance
in long-term cognitive testing.
Additionally, to our knowledge, no studies have been
conducted associating APOE genotypes with lipid-soluble
vitamin levels in the blood and micronutrient absorption in
pediatric populations, which is important for shedding light
on the effects of vitamin A in children. Interestingly, APOE4
carriers seem to be less prone to vitamin D-deficiency, as
extrapolated from population-wide APOE4 geographical
distributions (37). However, animal studies using APOE4
transgenic mice have found significantly lower alpha-toco-
pherol levels in the lung compared to APOE3 controls (38).
In support of our findings, vitamin A serum levels were
reported to be inversely correlated with the lactulose:man-
nitol ratio in marginally undernourished children living in
northeast Brazil (39). In addition, total intestinal parasite
numbers were significantly lower in children supplemented
with vitamin A (24). This vitamin has been found to enhance
intestinal cell migration and proliferation in vitro (40), both
of which could lead to improved intestinal barrier function.
Interestingly, our findings suggest an important interac-
tion between ApoE and vitamin A in improving intestinal
barrier function. The mechanisms underlying this interac-
tion remain unclear. However, mice lacking megalin
(megalin
lox/lox, apoE
Cre), a type 1 membrane protein
belonging to the low-density lipoprotein (LDL) receptor
gene family, which is therefore an ApoE ligand, may play
an essential role in systemic vitamin A homeostasis by
enhancing retinol recycling in the kidney (41).
Similar to zinc and vitamin A, glutamine is a gut-tropic
nutrient that could work in concert with the ApoE4 peptide
to maintain intestinal integrity (23). Thus, improvement of
anthropometric indicators in the short-run implies that
APOE4-positive patients are, in fact, responsive to gluta-
mine, especially in association with vitamin A, potentially
leading to better long-term effects, as in the case of
cognition. The data presented herein support this hypoth-
esis in that there was no significant correlation found
between growth gains and cognitive performance among
APOE4-negative individuals receiving any kind of supple-
mentation. We also found in murine models that glutamine
supplementation early in life was beneficial for hippocam-
pal plasticity following clustered litter size-induced under-
nutrition, while it did not affect growth itself (23). The
combined effect of APOE4 and glutamine regarding
ameliorating delayed verbal learning and verbal recall
effects may be a result of increased activity in the prefrontal
cortex and parietal lobes, as confirmed by other studies
associating neuroimaging with verbal learning and the
effects of APOE4 on working memory (42-44). From these
analyses, it appears that APOE4 may work synergistically
with glutamine in improving physical and brain develop-
ment in a setting where there is highly prevalent intestinal
dysfunction at baseline. These findings reinforce the
hypothesis that ApoE4 is especially beneficial when a
Figure 2 - Scatter plots indicating significant positive Pearson
correlations between the changes in anthropometric indicators
over 4 months and cognitive testing in the APOE4(+) population
receiving glutamine supplementation: (A) DHAZ* (t4-t0)v s .
WRAML-delayed verbal learning (n=21); (B) DWAZ* (t4-t0) vs.
TONI-3-IQ (n=21); and (C) DWHZ* (t4-t0) vs. TONI-3-IQ (n=21).
*HAZ=height-for-age z-scores, WAZ=weight-for-age z-scores,
WHZ=weight-for-height z-scores.
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16pathological stressor is present, such as an enteric infection,
as seen in earlier cohort studies in shantytown children with
heavier diarrheal burdens (3,14). Extra vigilance may be
required in supplying APOE4-negative children with
critical nutrients to combat the effects of malnutrition and
enteric disease. This is shown by the data indicating benefits
across supplementation arms among APOE4 non-carriers
between improved intestinal barrier function (lower L/M
ratios) and better verbal learning and IQ scores. It is possible
that improved intestinal integrity indicates less intestinal
inflammation from enteric diseases and better absorption of
nutrients that support adequate brain development.
We acknowledge that this is an exploratory study limited
by insufficient breastfeeding data, which is a potentially
confounding factor with respect to the cognitive outcomes
observed in the shantytown children in this study.
However, breastfeeding has historically not been found to
be a significant confounder in research on this study
population, as breastfeeding rates have mostly been homo-
genous in these limited study settings (14,16,22,45). We
realize that our findings are limited by the sample size used,
as it necessitated pooled statistical analyses of APOE-
genotyped children receiving glutamine, zinc, or vitamin
A. As a result of using pooled data for each supplementa-
tion arm analysis, the mixed and nutrient-to-nutrient
biological relationships may have masked the effects of
individual nutrients associated with the various APOE
backgrounds. The small study population also prevented us
from performing statistical analysis of the placebo group.
Further studies are needed with larger numbers of
participants and longer follow-up times to confirm the
association of APOE4 and cognitive development in
children with improved intestinal barrier function.
A strength of this study is that it is the first study
associating APOE genotypes, long-term cognitive outcomes,
and intestinal barrier function in children, most of whom
were living in a setting endemic for diarrheal diseases and
malnutrition. Due to these factors, we find our results to be
sufficiently significant to guide future clinical and pre-
clinical research on the direct effects of APOE4 on childhood
development and how such activity reflects an individual’s
enteric absorptive function, affecting cognitive outcomes.
We have documented a potentially beneficial synergistic
relationship between an APOE4 background and glutamine
in improving growth and cognitive outcomes in Brazilian
shantytown children presenting various degrees of malnu-
trition and intestinal barrier dysfunction. We also high-
lighted a particularly important aspect of the brain-gut axis,
where nutritional supplementation is vital for reducing
baseline intestinal inflammation caused by enteric disease,
which may help propagate nutrient absorption and improve
brain development. More studies are warranted to further
confirm the findings of this work and elucidate the potential
synergistic mechanisms of glutamine and ApoE4 action.
Transgenic mice expressing the human ApoE4 peptide
could be subjected to models of malnutrition and enteric
infections to explore the questions raised herein.
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